|
RIGL Rigel Pharmaceuticals Inc 1034842 |
| Balance Sheet |
|
Current Assets
|
135,103,000 |
|
Assets
|
163,976,000 |
|
Current Liabilities
|
63,299,000 |
|
Liabilities
|
160,688,000 |
|
Equity
|
3,288,000 |
|
Shares Out
|
17,595,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
31,471,000 |
|
Investing Cash Flow
|
4,130,000 |
| Market Analysis |
Market Cap
|
245,801,735 |
|
Price
|
20.56 |
|
BVPS
|
0.19 |
|
PB
|
108.72 |
|
EPS
|
-0.81 |
|
PS
|
0.34 |
|
FCF
|
35,601,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RIGL documents filed with the SEC.
RIGL Filings
Clear
